Drug Profile
TPX 200
Alternative Names: TPX-200Latest Information Update: 28 Feb 2018
Price :
$50
*
At a glance
- Originator OrthoTrophix
- Class Peptides
- Mechanism of Action Extracellular matrix protein modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified
Most Recent Events
- 28 Feb 2018 No recent reports of development identified for preclinical development in Undefined in USA
- 04 Feb 2016 Preclinical development is ongoing in USA
- 22 Aug 2013 Preclinical trials in Undefined indication (disorders associated with chronic kidney disease) in USA (unspecified route)